RecruitingNCT05966038
ALS/MND Natural History Study Data Repository
Studying Kennedy disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Massachusetts General Hospital
- Principal Investigator
- Alexander ShermanMassachusetts General Hospital
- Enrollment
- 5000 enrolled
- Eligibility
- 18-90 years · All sexes
- Timeline
- 2015 – 2030
Study locations (16)
- Loma Linda University Health, Loma Linda, California, United States
- Kaiser Permanente, Los Angeles, California, United States
- University of Florida, Gainesville, Florida, United States
- Northwestern University, Chicago, Illinois, United States
- Lahey Clinic, Burlington, Massachusetts, United States
- Henry Ford Health System, Detroit, Michigan, United States
- University of Minnesota, Minneapolis, Minnesota, United States
- Saint Louis University, St Louis, Missouri, United States
- Providence ALS Clinic, Portland, Oregon, United States
- Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania, United States
- University of Pittsburgh, Pittsburgh, Pennsylvania, United States
- Virginia Commonwealth University, Richmond, Virginia, United States
- Hadassah Medical Organization, Jerusalem, Israel
- Tel Aviv Medical Center, Tel Aviv, Israel
- Centro Clinico NEMO Milano, Milan, Italy
- +1 more locations on ClinicalTrials.gov
Collaborators
Henry Ford Health System · Northwestern University · Temple University · St. Louis University · University of Florida · University of Minnesota · Virginia Commonwealth University · Fondazione Serena Onlus - Centro Clinico NeMO Milano · Providence Health & Services · University of Pittsburgh · Istituti Clinici Scientifici Maugeri SpA · Lahey Clinic · Hadassah Medical Organization · Tel Aviv Medical Center · Kaiser Permanente
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05966038 on ClinicalTrials.govOther trials for Kennedy disease
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2, PHASE3NCT06862596Clinical Trial of Mexiletine Hydrochloride for Spinal and Bulbar Muscular AtrophyMasahisa Katsuno
- ACTIVE NOT RECRUITINGNCT07443449International SBMA Project (KDA)Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
- RECRUITINGPHASE2NCT06169046A Placebo-controlled Study of Clenbuterol in Spinal and Bulbar Muscular AtrophyGianni Soraru
- RECRUITINGNANCT04944940Clinical, Molecular and Imaging Biomarkers in Spinal and Bulbar Muscular Atrophy (SBMA)National Institute of Neurological Disorders and Stroke (NINDS)
- RECRUITINGNANCT03555578Specified Drug-Use Survey of Leuprorelin Acetate Injection Kit 11.25 mg "All-Case Investigation: Spinal and Bulbar Muscular Atrophy (SBMA)"Takeda